1. Home
  2. ICCC

ICCC

ImmuCell Corporation

Logo ImmuCell Corporation

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-24-2024 4:00pm EST

$
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Founded: 1982 Country:
United States
United States
Employees: N/A City: PORTLAND
Market Cap: 39.1M IPO Year: 1987
Target Price: N/A AVG Volume (30 days): 7.2K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.75 EPS Growth: N/A
52 Week Low/High: $4.26 - $6.05 Next Earning Date: 05-09-2024
Revenue: $17,471,669 Revenue Growth: -5.90%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

Share on Social Networks: